Page last updated: 2024-10-26

droperidol and Cancer of Larynx

droperidol has been researched along with Cancer of Larynx in 1 studies

Droperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
droperidol : An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, S1
Fukuda, H1
Kitahara, S1

Other Studies

1 other study available for droperidol and Cancer of Larynx

ArticleYear
Stroboscopic microsurgery of the larynx.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1975, Volume: 101, Issue:3

    Topics: Adult; Atrophy; Cysts; Droperidol; Fentanyl; Granuloma; Humans; Keratosis; Laryngeal Diseases; Laryn

1975